Scientists Transform Enigmatic Cell Structures Into Devices for Recording RNA Activity
Researchers have engineered the naturally occurring vault particle into a synthetic "TimeVault" that sequesters mRNA inside the ribonucleoprotein shell, protecting it from degradation for more than a week. By fusing a major‑vault‑protein binding domain with an mRNA‑binding motif, the system creates a cellular time capsule that can be retrieved and sequenced later. The study demonstrated accurate capture of transient stress‑response transcripts and identification of pre‑treatment resistance genes in lung‑cancer cells. While currently limited to bulk RNA‑seq and a ~seven‑day window, the platform promises time‑resolved transcriptomics without continuous imaging.
New SLAC Method Guides Better Cell Slice Preparation for Cryo-ET Imaging
SLAC National Accelerator Laboratory researchers have introduced a tri‑coincident system that synchronizes a scanning electron microscope, an ion‑beam mill, and an optical microscope to guide cryogenic electron tomography (cryo‑ET) sample preparation. By exploiting interference patterns in fluorescent light emitted from...
Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of C. Diff Drug
Vedanta Biosciences announced a major headcount reduction, cutting roughly half of its workforce to preserve cash for a Phase III trial of its oral C. difficile candidate VE303. The layoffs follow earlier cuts after a failed Phase II study of VE202 and reflect...
Microglial FcγR Drives Dopaminergic Neuron Loss
A new study reveals that microglial Fcγ receptors (FcγR) actively drive the loss of dopaminergic neurons, a hallmark of Parkinson's disease. Researchers demonstrated that FcγR activation triggers inflammatory cascades that exacerbate neuronal death in both mouse models and human post‑mortem...
ImmunityBio's Cell Therapy Posts Encouraging Early Data in Rare Blood Cancer
ImmunityBio reported encouraging early data from its off‑the‑shelf cell‑therapy platform in a Phase 1 trial (QUILT) targeting a rare form of lymphoma. The small study demonstrated a favorable safety profile and preliminary efficacy signals, including objective responses in several patients. The...
Regulate DNA Fragments to Bypass Synthesis Screening
A proposed regulatory framework would allow short synthetic DNA fragments to bypass mandatory synthesis screening, aiming to streamline research and reduce costs. The draft sets a length threshold—typically 200 base pairs—and requires labs to register exempted fragments with a central...
Medications for Opioid Use Disorder: Overcoming Integration Barriers
Researchers Desai et al. identify persistent barriers that prevent medication‑assisted treatment (MAT) for opioid use disorder from being fully integrated into specialty programs. Stigma toward patients and providers, restrictive regulations, and insufficient clinician training limit the use of proven drugs such...
UC San Diego Launches ARPA-H Project to 3D Bioprint Patient-Specific Human Livers
UC San Diego, backed by a $25.8 million ARPA‑H grant, is developing a 3‑D bioprinting platform to create patient‑specific, functional human livers. The multidisciplinary team combines rapid light‑based printing with AI‑driven vascular design to fabricate complex, multi‑cellular tissue in seconds. Partnering...
JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer
Protagonist Therapeutics faces a pivotal choice on its rusfertide partnership with Takeda. The company is leaning toward opting out of the 50‑50 co‑development deal, which would trigger a $400 million opt‑out payment and tiered royalties up to 29% on sales exceeding...
Ensuring the Supply Chain Through Purchasing Controls
Establishing a secure supply chain now starts with early, cross‑functional purchasing controls. Development, quality, and procurement teams must collaborate to define requirements, qualify suppliers, and create quality agreements before scale‑up. The Parenteral Drug Association’s upcoming ANSI/PDA Standard 001‑2020 formalizes these expectations...
SÜDPACK Medica to Unveil Next-Generation Sustainable Packaging and Streamlined Services at Pharmapack Europe 2026
At Pharmapack Europe 2026, SÜDPACK Medica introduced its next‑generation PharmaGuard blister line, a mono‑material polypropylene solution that replaces multi‑layer composites with a recyclable, phthalate‑free film, now available in an opaque white version for better dosage readability. The company also launched...
#JPM26: Sandoz CEO on Ozempic Generic Launch Plans for 2026
Sandoz, Novartis' generics arm, announced plans to launch a generic version of Ozempic (semaglutide) in 2026. The move aligns with the anticipated expiration of Novo Nordisk's patents on the GLP‑1 drug, opening the U.S. and European markets to lower‑priced alternatives....
Wegovy Pill Shows Strong Early Uptake, as Rival Looms
Novo Nordisk's oral Wegovy pill recorded 3,071 prescriptions within its first four days on the U.S. market, a figure that excludes sales through its NovoCare direct‑to‑consumer channel. The launch arrives as Eli Lilly awaits an FDA decision on its own oral...
JPM 2026: What’s the Outlook Like This Year?
The J.P. Morgan Healthcare Summit in San Francisco highlighted a surge in radiopharmaceutical development, positioning precision radiation therapy as a key growth area in oncology. AI‑driven molecular profiling is accelerating biomarker discovery and drug design, while the GLP‑1 market expands with...
Sanofi Linked to Takeover Bid for Ocular Therapeutix
Sanofi is reportedly preparing a renewed takeover bid for US‑based Ocular Therapeutix after its initial $16‑per‑share offer was rejected last summer. Ocular, valued at roughly $2.4 billion with shares trading around $11.28, is poised to file for approval of Axpaxli, a...
JPM26: Deal Hungry Novo Moves With ‘Intention’ To Put Metsera in the Rearview
Novo Nordisk is revamping its business‑development approach under new CEO Mike Maziar Doustdar, emphasizing intentional M&A and licensing to accelerate its obesity and diabetes pipeline. The company recently closed a $5.2 billion acquisition of Akero Therapeutics and secured a China partnership...
Komodo Health Appoints Amit Sangani to Chief Technology Officer
Komodo Health announced Amit Sangani as its new chief technology officer, tasked with steering the AI‑native Marmot platform. Sangani arrives after an 11‑year tenure at Meta, where he led large‑scale AI systems including PyTorch and Llama, and previously co‑founded MightyText....
Former Emergent CEO Hit With Insider Trading Lawsuit
The New York Attorney General sued former Emergent BioSolutions CEO Robert Kramer for alleged insider trading, claiming he sold stock based on nonpublic knowledge of vaccine contamination. Kramer reportedly profited over $10.1 million from trades executed between November 2020 and early 2021....
Writing the Code of Life: Synthetic Human Chromosomes on the Horizon
The Wellcome‑funded Synthetic Human Genome (SynHG) project has launched a £10 million, five‑year effort to develop scalable technologies for building synthetic human chromosomes. The consortium of five UK universities aims to create the first fully synthetic human genome, tackling challenges from...
Automated Twist Bioscience NGS Library Prep Workflows Enabled on SPT’s Firefly
SPT Labtech has launched validated automated workflows for Twist Bioscience’s next‑generation sequencing (NGS) library preparation kits on its firefly® liquid handling platform. The initial offering supports the FlexPrep™ UHT kit and integrates the Twist Enzymatic Fragmentation Kit 2.0, delivering higher‑throughput,...
JPM26: Korro Bio Looks To Save Itself Despite Unenviable Position
Korro Bio’s lead RNA‑editing candidate KRRO‑110 failed its Phase I/IIa trial for alpha‑1 antitrypsin deficiency, prompting an 80% stock plunge and a one‑third staff layoff. A root‑cause analysis revealed the lipid nanoparticle delivery vehicle achieved only about 25% of the...
European Regulators Recommended 38 Novel Drugs in 2025, 15 Fewer than the FDA
The European Medicines Agency (EMA) recommended 104 medicines for approval in 2025, marking the second‑highest total in the past 15 years. Of those, 38 are classified as novel drugs, a figure that trails the U.S. Food and Drug Administration (FDA)...
Ocugen Shares Fall, Despite Positive Eye Disorder Trial
Ocugen reported that its phase‑2 ArMaDa trial of the gene therapy OCU410 achieved a 46% reduction in geographic atrophy lesion growth for medium and high doses, with the medium dose showing a 54% reduction. The data also revealed a 60%...
Novo Nordisk, BioMarin Make AI Moves; Bristol Myers Welcomes Neurology Exec From Eisai
Novo Nordisk and BioMarin announced strategic partnerships to integrate artificial intelligence into their drug discovery pipelines, aiming to accelerate candidate identification and reduce development costs. Novo Nordisk highlighted a collaboration with a leading AI firm to model peptide therapeutics, while...
Autonomous AI Can Spot Cognitive Decline in Medical Notes
Researchers at Mass General Brigham unveiled an autonomous, agentic AI system that scans routine clinical notes to flag early cognitive impairment. The platform, built from five specialized LLM agents, demonstrated 98% specificity and 91% sensitivity in balanced testing, though real‑world...
EDETEK Launches “Ensemble” AI Managed Services
EDETEK Inc. unveiled Ensemble, an AI‑managed service that operationalizes validated, human‑supervised artificial intelligence across the clinical development lifecycle. The offering combines best‑fit large language and multimodal models, agentic automation, and domain experts to deliver production‑grade outputs such as SAP, SDTM,...
Immune-Regulating Lipid Signals May Provide a Path to Treat Chronic Inflammation
Scientists at University College London identified epoxy‑oxylipins as natural brakes that curb chronic inflammation by limiting intermediate monocyte expansion. In a human trial, the soluble epoxide hydrolase inhibitor GSK2256294 boosted epoxy‑oxylipin levels, accelerated pain resolution and lowered monocyte counts, though...
Psychiatric Nurses’ Views on AI in Care
A recent qualitative study of Chinese psychiatric nurses reveals a nuanced stance toward artificial intelligence in mental‑health care. Nurses largely view AI as a supportive tool that can automate routine tasks and enhance decision‑making, yet they voice strong concerns about...
Plant Discovery Could Lead to New Ways of Producing Medicines
Researchers at the University of York identified a bacterial‑like gene in the plant Flueggea suffruticosa that drives production of the potent alkaloid securinine, revealing that plants can co‑opt microbial enzymes for chemical defense. This discovery shows the gene family is...
Labiotech’s 15 Biopharma Companies to Watch in 2026
Labiotech‑EU hosted a special podcast where journalists Jules Adam, Roohi Peter and Willow Shah‑Neville each highlighted five biotech firms they expect to shape 2026, creating a curated list of 15 companies. The selections span gene‑therapy, immunology, neuroscience and platform technologies, featuring names such...
Patient Perspectives on Frailty Screening in Emergencies
A qualitative study published in BMC Geriatrics explores how emergency‑department patients experience frailty screening. Researchers interviewed older adults to capture feelings ranging from anxiety about being labeled frail to relief at receiving tailored care. The findings highlight how the hectic...
Revealing RNA Polymerase II Start Sites via csRNA-Seq
A new study introduces csRNA‑seq, a high‑resolution method that captures active RNA Polymerase II transcription start sites across the genome. The technique isolates short, capped RNAs, enabling precise mapping of promoter activity without requiring chromatin immunoprecipitation. Early validation in human...
Restoring FBP1 Boosts Erectile Function in Diabetic Mice
A recent pre‑clinical study demonstrated that restoring the enzyme fructose‑1,6‑bisphosphatase 1 (FBP1) in diabetic mice markedly improves erectile function. The researchers used a targeted gene‑therapy approach to re‑express FBP1 in penile tissue, which rescued nitric oxide signaling and vascular responsiveness. Treated...
Resolving DNA Origami Structural Integrity and Pharmacokinetics in Vivo
The study introduces PLASTIQ, a proximity‑ligation assay that quantifies intact DNA origami structures in vivo with single‑helix resolution. Using ligatable staple pairs, the method detects intact nanostructures from as little as 1 µl of blood, achieving a 0.01 fM detection limit. PLASTIQ...
Agenus Closes Strategic Immunotherapeutic Collaboration with Zydus Lifesciences
Agenus finalized a $141 million strategic collaboration with Zydus Lifesciences to accelerate development and potential commercialization of its botensilimab‑balstilimab (BOT+BAL) immunotherapy combo. The deal grants Zydus exclusive rights to develop and sell BOT and BAL in India and Sri Lanka, while...
Lipid Droplets: Dynamics and Organelle Interactions Explored
Recent research uncovers how lipid droplets (LDs) dynamically interact with mitochondria, endoplasmic reticulum, and lysosomes, reshaping our understanding of intracellular lipid management. High‑resolution live‑cell imaging shows rapid LD‑organelle contact formation that regulates energy production, lipid synthesis, and autophagic turnover. The...
Quantum Tools Set to Transform Life Science, Researchers Say
Japan’s National Institutes for Quantum Science and Technology (QST) published a perspective in ACS Nano outlining how quantum tools—nanoscale biosensors, hyper‑polarized MRI, and quantum‑biology‑inspired catalysts—can shift life‑science from niche labs to routine clinical and industrial use. The roadmap highlights diamond‑based nitrogen‑vacancy...
JPM Momentum and Asia’s Hotbeds of Innovation — a BioCentury Podcast
The J.P. Morgan Healthcare Conference ignited a surge of financing, the strongest in years for biotech. In a special BioCentury This Week podcast recorded at the conference, analysts and investors examined Asia’s burgeoning biotech ecosystems. Discussions covered deal pricing in China, the...
2026 U.S. Drug Pricing Outlook: ‘MFN’ Is the Future
The article forecasts that the United States will adopt a most‑favored‑nation (MFN) drug‑pricing model, tying domestic prices to international reference benchmarks. Policymakers view MFN as a tool to curb soaring prescription costs, while industry groups warn it could compress profit...
Exploring Quinoxalinyl and Quinolinyl Compounds as ALK5 Inhibitors
Researchers have synthesized a series of quinoxalinyl and quinolinyl derivatives targeting the ALK5 kinase, a key driver of fibrotic signaling. In biochemical assays, several compounds achieved sub‑micromolar potency and demonstrated high selectivity against related TGF‑β receptors. Cellular studies showed these...
Exploring Metabolic Noise Opens New Paths to Better Biomanufacturing
Washington University researchers identified enzyme copy‑number fluctuations as the primary source of metabolic noise in engineered E. coli producing the yellow pigment betaxanthin. By combining microfluidic single‑cell tracking with a bright‑fluorescent metabolite, they observed rapid switches between high‑ and low‑production states....
New York Sues Ex-Emergent CEO over Insider Trading During Vaccine Manufacturing Struggle
New York Attorney General sued the former chief executive of Emergent BioSolutions, alleging he engaged in insider trading while the company grappled with contamination problems at its Baltimore plant that delayed AstraZeneca’s COVID‑19 vaccine production. Prosecutors claim the executive sold...
How Beige Fat Works to Promote Healthy Blood Pressure in Mice
Researchers at Rockefeller University demonstrated that loss of beige fat in mice triggers hypertension. Mice engineered to lack the beige‑fat regulator PRDM16 develop perivascular fibrosis and heightened sensitivity to angiotensin II. The study identified the secreted enzyme QSOX1 as the...
Hybrid Polymer Nanocarriers Improve Pulmonary mRNA Vaccine Delivery
A research team at Ludwig Maximilian University of Munich has created hybrid polymer nanocarriers combining PLGA and PBAEs to deliver inhalable mRNA vaccines. The system penetrates airway mucus, escapes endosomes, and transfects immune cells more efficiently than existing lipid nanoparticles....
Inside Fosun Pharma's Ambition to Reach Outside of China
Shanghai‑based Fosun Pharmaceutical is accelerating its transformation from a domestic generic manufacturer into a global innovator. The group has earmarked billions of dollars for overseas R&D hubs, strategic biotech partnerships and a new $2.5 billion bond to fund its expansion. Recent...
OpenAI Invests in Sam Altman’s Brain Computer Interface Startup Merge Labs
OpenAI wrote the lead check in Merge Labs’ $250 million seed round, valuing the Sam Altman‑backed brain‑computer interface startup at $850 million. Merge Labs aims to create non‑invasive BCIs that use molecular carriers and ultrasound to communicate with neurons, positioning itself as...
Alfasigma Gains Neuro Treatment; BridgeBio Offers $550M in Notes
Alfasigma has secured worldwide rights to a parenteral formulation of adibelivir for the treatment of HSV encephalitis, an ultra‑rare neurological condition. The agreement positions Alfasigma to commercialize the therapy across major markets. Meanwhile, BridgeBio announced a $550 million senior unsecured note...
Boston Scientific to Acquire Penumbra for $14.5B
Boston Scientific announced a $14.5 billion acquisition of Penumbra, paying $374 per share in cash and stock. Penumbra’s portfolio of clot‑removal and embolization devices will broaden Boston Scientific’s reach into fast‑growing thrombectomy and vascular bleeding markets. The deal values Penumbra at...
Selective GlcNAc to GalNAc Epimerization via Kinetic Control
The latest Bioengineer roundup highlights several cutting‑edge chemical and biological advances. A thermal [2+2] cycloaddition delivers gem‑difluoro bicycloalkanes, while cobalt‑catalyzed siloxycarbene chemistry enables efficient thioester coupling. Researchers also report a homologative difunctionalization method that broadens alkene functionalization, a biocompatible ligand...
Monitoring Beer Fermentation at the Single-Cell Level with a Novel Raman Method
Scientists at the Qingdao Institute of Bioenergy and Bioprocess Technology have introduced “process ramanomics,” a single‑cell Raman spectroscopy workflow that monitors beer fermentation in real time. By capturing Raman fingerprints from individual yeast cells, the method accurately predicts 19 extracellular...